Publication & Citation Trends
Most Cited Works
Publications
16 total
OR03-2 Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus PDF
Cited by 3
OpenAlex
Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial Design PDF
Cited by 36
OpenAlex
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes PDF
Cited by 872
OpenAlex
Combination of a Beta Adrenoceptor Modulator and a Norepinephrine-Serotonin Uptake Inhibitor for the Treatment of Obesity PDF
Cited by 7
OpenAlex
Book Review / Erratum
Cited by 0
OpenAlex
Effect of Teriparatide {rhPTH(1-34)} on BMD When Given to Postmenopausal Women Receiving Hormone Replacement Therapy
Cited by 60
OpenAlex
Use of IV isoproterenol test as a biomarker in a first-in-man study: Pilot investigation with LY, a combined beta3 agonist/beta1 antagonist
Cited by 0
OpenAlex
A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis
Cited by 361
OpenAlex
Research Topics
Bone health and treatments
(7)
Bone health and osteoporosis research
(4)
Fibroblast Growth Factor Research
(3)
Bone Metabolism and Diseases
(2)
Pharmacology and Obesity Treatment
(2)
Frequent Co-Authors
Affiliations
United States Department of Veterans Affairs
Eli Lilly (United States)
Veterans Health Administration
Yale University
University of New Haven